Ungab, Alolueva .

HRN: 24-75-72  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2025
AMPICILLIN 1GM (VIAL)
10/01/2025
10/03/2025
IVT
2g
Q6
Prom
Checking Initial Appropriateness 
10/01/2025
CEFUROXIME 1.5GM (VIAL)
10/01/2025
10/01/2025
IVT
1.5g
Ptor
Stat Cs
Checking Initial Appropriateness 
10/02/2025
CEFUROXIME 1.5GM (VIAL)
10/02/2025
10/03/2025
IVT
1.5g
Q8
S/P CS
Checking Initial Appropriateness 
10/02/2025
CEFUROXIME 500MG (TAB)
10/02/2025
10/10/2025
PO
500mg
BID
S/P CS
Checking Initial Appropriateness 
10/02/2025
METRONIDAZOLE 500MG (TAB)
10/02/2025
10/10/2025
PO
500mg
TID
S/P CS
Checking Initial Appropriateness 
10/02/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/02/2025
10/03/2025
IV
500mg
Q8
S/P CS
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: